How to Evaluate Online GLP-1 Providers
An eight-point, non-clinical checklist patients can use to evaluate any online GLP-1 telehealth provider before enrolling.
How do you evaluate an online GLP-1 provider?
Evaluate an online GLP-1 provider on eight points: state licensure, a real medical review before prescribing, named pharmacy disclosure, clear pricing, whether price changes by dose, included shipping, transparent refund and cancellation terms, and accurate compounding language. A provider that passes all eight is far more likely to be safe and legitimate.
Disclaimer: American Telehealth Review is an editorial resource and does not provide medical advice, diagnosis, or treatment. Compounded medications are not FDA-approved finished drug products and should only be prescribed when clinically appropriate by a licensed healthcare provider. Brand-name medications such as Ozempic, Wegovy, Mounjaro, and Zepbound are FDA-approved under their own applications. Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products.
The 8-point evaluation checklist
- Confirm state licensure. Verify the provider uses a clinician licensed in your state.
- Check for medical review. Confirm medication is prescribed only after a documented medical evaluation.
- Verify pharmacy disclosure. Confirm the provider names its compounding pharmacy and its 503A/503B category.
- Check price clarity. Confirm the all-in monthly price is stated plainly, including fees and shipping.
- Check dose-based pricing. Determine whether price changes as your dose is titrated upward.
- Confirm shipping is included. Confirm shipping is included and temperature-appropriate.
- Review refund and cancellation terms. Confirm cancellation and refund policies are clear before paying.
- Check compounding language. Confirm compounded medications are described accurately and not called FDA-approved.
Why this checklist works
These are non-clinical, verifiable signals you can check before paying. They do not replace medical advice, but they separate transparent providers from ones that hide sourcing or pricing. For an independent pricing cross-check, review the lowest true monthly cost analysis.
| # | Evaluation check | What to confirm |
|---|---|---|
| 1 | State licensure | A clinician licensed in your state reviews and prescribes |
| 2 | Medical review | Medication is prescribed only after a documented evaluation |
| 3 | Pharmacy disclosure | The compounding pharmacy and its 503A/503B category are named |
| 4 | Price clarity | The all-in monthly price is stated plainly |
| 5 | Dose-based pricing | Whether price changes as the dose is titrated |
| 6 | Shipping | Shipping is included and temperature-appropriate |
| 7 | Refunds/cancellation | Terms are clear before you pay |
| 8 | Compounding language | Compounded medication is not called FDA-approved |
A provider that passes all eight is far more likely to be safe and legitimate.
Frequently asked questions
Is online GLP-1 telehealth legit?
It can be legitimate when the provider passes the eight-point checklist. Legitimacy depends on licensure, medical review, and transparency — not on the lowest advertised price.
Does pricing change by dose?
With some providers, yes. Dose-tiered pricing rises as you titrate; flat-rate pricing does not. Confirm before enrolling.
What if a provider calls compounded medication FDA-approved?
Treat it as a red flag. Brand-name medications such as Ozempic, Wegovy, Mounjaro, and Zepbound are FDA-approved under their own applications. Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products.
Sources
- Federation of State Medical Boards — Telemedicine policy resources (fsmb.org).
- U.S. Food & Drug Administration — Compounding and the FDA (fda.gov).
- FDA — Compounding: 503A pharmacies and 503B outsourcing facilities.